{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:36:12Z","timestamp":1788669372675,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-016-1385-6","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T13:07:04Z","timestamp":1454591224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Role of oral Minocycline in acute encephalitis syndrome in India \u2013 a randomized controlled trial"],"prefix":"10.1186","volume":"16","author":[{"given":"Rashmi","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakanta","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra","family":"Atam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Shanker","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"key":"1385_CR1","unstructured":"Japanese encephalitis surveillance standards. Available from: http:\/\/www.path.org\/files\/WHO_surveillance_standards_JE.pdf . Accessed September 10, 2014."},{"key":"1385_CR2","unstructured":"Economic Profile of Uttar Pradesh Available from: http:\/\/www.economywatch.com\/stateprofiles\/uttarpradesh\/profile.htm . Accessed September 10, 2014."},{"key":"1385_CR3","doi-asserted-by":"crossref","unstructured":"Roop Kumari, Pyare L Joshi A review of Japanese encephalitis in Uttar Pradesh, India. WHO South-East Asia Journal of Public Health 2012;1(4):374-395. Ministry of Health & Family Welfare, Government of India Operational Guidelines Japanese encephalitis vaccination in India September 2010.","DOI":"10.4103\/2224-3151.207040"},{"key":"1385_CR4","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","volume":"95","author":"J Yrjanheikki","year":"1998","unstructured":"Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. Tetracyclines Inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA. 1998;95:15769\u201374.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1385_CR5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.10242","volume":"52","author":"KL Arvin","year":"2002","unstructured":"Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol. 2002;52:54\u201361.","journal-title":"Ann Neurol"},{"key":"1385_CR6","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","volume":"96","author":"J Yrjanheikki","year":"1999","unstructured":"Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative minocycline reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Nat Acad Sci USA. 1999;96:13496\u2013500.","journal-title":"Proc Nat Acad Sci USA"},{"key":"1385_CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","volume":"417","author":"S Zhu","year":"2002","unstructured":"Zhu S, Stavrovskaya IG, Drozda M, et al. Minocycline inhibits cytochrome C release and delays progression of amyotrphic lateral sclerosis in mice. Nature. 2002;417:74\u20138.","journal-title":"Nature"},{"key":"1385_CR8","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/brain\/awg178","volume":"126","author":"J Wells","year":"2003","unstructured":"Wells J, Hurlbert J, Fehlings M, Yong VW. Neuroprotection by Minocycline facilitates significant recovery from spinal cord injury. Brain. 2003;126:1628\u201337.","journal-title":"Brain"},{"key":"1385_CR9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/089771503770195867","volume":"20","author":"SM Lee","year":"2003","unstructured":"Lee SM, Yune TY, Kim SJ, et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma. 2003;20:1017\u201327.","journal-title":"J Neurotrauma"},{"key":"1385_CR10","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1523\/JNEUROSCI.5275-03.2004","volume":"24","author":"DP Stirling","year":"2004","unstructured":"Stirling DP, Khodarahmi K, Liu J, et al. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci. 2004;24:2182\u201390.","journal-title":"J Neurosci"},{"key":"1385_CR11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.20111","volume":"55","author":"LM Metz","year":"2004","unstructured":"Metz LM, Zhang Y, Yeung M, et al. Minocycline reduces gadolinium enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2004;55:756.","journal-title":"Ann Neurol"},{"key":"1385_CR12","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S, et al. Minocycline prevents nigrostraital dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. Proc Nat Acad Sci USA. 2001;98:14669\u201374.","journal-title":"Proc Nat Acad Sci USA"},{"key":"1385_CR13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, et al. Minocycline inhibits caspase \u22121 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington\u2019s disease. Nat Med. 2000;6:797\u2013801.","journal-title":"Nat Med"},{"key":"1385_CR14","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/diabetes.54.5.1559","volume":"54","author":"JK Krady","year":"2005","unstructured":"Krady JK, Basu A, Allen CM, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase \u22123 activation in a rodent model of diabetic retinopathy. Diabetes. 2005;54:1559\u201365.","journal-title":"Diabetes"},{"key":"1385_CR15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.10092","volume":"51","author":"N Popovic","year":"2002","unstructured":"Popovic N, Schubart A, Goetz BD, Zhang SC, Linington C, Duncan ID. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol. 2002;51:215\u201323.","journal-title":"Ann Neurol"},{"key":"1385_CR16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2004.11.015","volume":"192","author":"SM Richardson-Burns","year":"2005","unstructured":"Richardson-Burns SM, Tyler KL. Minocycline delays disease onset and mortality in reovirus encephalitis. Exp Neurol. 2005;192:331\u20139.","journal-title":"Exp Neurol"},{"key":"1385_CR17","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","volume":"293","author":"MC Zink","year":"2005","unstructured":"Zink MC, Uhrlaub J, DeWitt J, et al. Neuroprotective and anti-human immunodeficiency virus activity of Minocycline. JAMA. 2005;293:2003\u201311.","journal-title":"JAMA"},{"key":"1385_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkm307","volume":"40","author":"M Michealis","year":"2007","unstructured":"Michealis M, Kleinschmidt MC, Doerr HW, Cinalt Jr J. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother. 2007;40:981\u20136.","journal-title":"J Antimicrob Chemother"},{"key":"1385_CR19","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1471-4159.2008.05238.x","volume":"105","author":"MK Mishra","year":"2006","unstructured":"Mishra MK, Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction and viral replication following Japanese encephalitis. J Neurochem. 2006;105:1582\u201395.","journal-title":"J Neurochem"},{"key":"1385_CR20","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1371\/journal.pntd.0000437","volume":"3","author":"D Ghosh","year":"2009","unstructured":"Ghosh D, Basu A. Japanese encephalitis \u2013 a pathological and clinical perspective. PLOS Neglected Tropical diseases. 2009;3:e437.","journal-title":"PLOS Neglected Tropical diseases"},{"key":"1385_CR21","first-page":"467","volume":"133","author":"K Dutta","year":"2011","unstructured":"Dutta K, Basu A. use of minocycline in viral infection. Indian J Med Res. 2011;133:467\u201370.","journal-title":"Indian J Med Res"},{"key":"1385_CR22","first-page":"613","volume":"80","author":"DA Gadkari","year":"1984","unstructured":"Gadkari DA, Shaikh BH. IgM antibody capture ELISA in the diagnosis of Japanese encephalitis, West Nile & dengue virus infections. Indian J Med Res. 1984;80:613\u20139.","journal-title":"Indian J Med Res"},{"key":"1385_CR23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(75)92830-5","volume":"1","author":"B Jennett","year":"1975","unstructured":"Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480\u20134.","journal-title":"Lancet"},{"key":"1385_CR24","first-page":"218","volume-title":"Designing Clinical Research : An Epidemiologic Approach","author":"SB Hulley","year":"1992","unstructured":"Hulley SB, Cummings SR. Designing Clinical Research : An Epidemiologic Approach. Baltimore: Williams & Wilkins; 1992. p. 218."},{"key":"1385_CR25","unstructured":"Amit Shanker Singh, Piyush Tripathi, Saima Firdaus Khan, Amita Jain, Virendra Atam, Rashmi Kumar Non neurological manifestations in acute encephalitis syndrome in Uttar Pradesh, India. J Neuroinfetious Dis 2014; 5: http:\/\/www.omicsonline.com\/open-access\/non-neurological-manifestations-in-acute-encephalitissyndrome-in-uttar-pradesh-india-2314-7326.1000143.pdf ."},{"key":"1385_CR26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/505121","volume":"43","author":"R Kumar","year":"2006","unstructured":"Kumar R, Tripathi P, Singh S, Banerjee G. Clinical features of children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh. India Clinical Infectious Diseases. 2006;43:123\u201331.","journal-title":"India. Clinical Infectious Diseases"},{"key":"1385_CR27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2007.12.018","volume":"269","author":"R Kumar","year":"2008","unstructured":"Kumar R, Tripathi S, Tambe JJ, Arora V, Srivastava A, Nag VL. Dengue encephalopathy in children in northern India: Clinical features and comparison with nondengue. J Neurol Sciences. 2008;269:41\u20138.","journal-title":"J Neurol Sciences"},{"key":"1385_CR28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s13312-010-0024-3","volume":"47","author":"N Rathi","year":"2010","unstructured":"Rathi N, Rathi A. Rickettsial Infections: Indian Perspective. Indian Pediatrics. 2010;47:157\u201364.","journal-title":"Indian Pediatrics"},{"key":"1385_CR29","doi-asserted-by":"crossref","unstructured":"Khan SA, Dutta P, Borah J, et al. Leptospirosis presenting as acute encephalitis syndrome (AES) in Assam, India. Asian Pacific Journal of Tropical Disease. 2012;151\u2013153.","DOI":"10.1016\/S2222-1808(12)60034-6"},{"key":"1385_CR30","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1086\/509330","volume":"43","author":"CA Glaser","year":"2006","unstructured":"Glaser CA, Honarmand S, Anderson LJ, et al. Beyond Viruses: Clinical Profiles and Etiologies Associated with Encephalitis. Clinical Infect Dis. 2006;43:1565\u201377.","journal-title":"Clinical Infect Dis"},{"key":"1385_CR31","unstructured":"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/050444s047lbl.pdf accessed 28th September 2014."},{"key":"1385_CR32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/cpt1973145852","volume":"14","author":"H Macdonald","year":"1973","unstructured":"Macdonald H, Kelly RG, Allen S, Noble JF, Kanegis LA. Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther. 1973;14:852\u201361.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1385_CR33","first-page":"119e","volume":"30","author":"SL Kang-Birken","year":"2010","unstructured":"Kang-Birken SL, Castel U, Prichard JG. Oral doxycycline for treatment of neurosyphilis in two patients infected with human immunodeficiency virus. Pharmacotherapy. 2010;30(4):119e\u201322e.","journal-title":"Pharmacotherapy"},{"key":"1385_CR34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1086\/515145","volume":"28","author":"L Dotewall","year":"1999","unstructured":"Dotewall L, Hagberg L. Successful oral doxycycline treatment of lyme disease associated facial palsy and meningitis. Clin Infect Dis. 1999;28:569\u201371.","journal-title":"Clin Infect Dis"},{"key":"1385_CR35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1086\/313604","volume":"30","author":"BA Cunha","year":"2000","unstructured":"Cunha BA. Minocycline versus Doxycycline in the Treatment of Lyme Neuroborreliosis. Clin Infect Dis. 2000;30:237\u20138.","journal-title":"Clin Infect Dis"},{"key":"1385_CR36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","volume":"15","author":"S Saivin","year":"1988","unstructured":"Saivin S, Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet. 1988;15:355\u201366.","journal-title":"Clin Pharmacokinet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1385-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T08:07:26Z","timestamp":1567584446000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2334\/16\/67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1385-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"67"}}